v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jan. 31, 2026
Apr. 30, 2025
Current assets:    
Cash $ 192 $ 1,493
Inventory 7,599 7,599
Total current assets 7,791 9,092
Total assets 7,791 9,092
Current liabilities:    
Accounts payable and accrued expense 216,670 172,082
Accrued licenses agreement payable 62,500 25,000
Accrued interest and fees payable 261,541 220,521
Convertible notes payable, net of discount 215,392 185,762
Derivative liabilities 68,645 31,866
Payables - related parties 1,014,693 747,208
Customer deposits 40,375 40,375
Stock payable 24,000 24,000
Notes payable 565,288 476,312
Note payable- related party 199,844 161,092
Total current liabilities 2,668,948 2,084,218
Total liabilities 2,668,948 2,084,218
Commitments and Contingencies 0 0
Stockholders' deficit:    
Common stock, $0.0001 par value; 600,000,000 shares authorized, 35,531,767 and 34,147,881 shares issued and outstanding, respectively 3,754 3,416
Additional paid-in capital 16,359,889 16,324,169
Accumulated deficit (18,628,736) (18,042,197)
Total (2,264,720) (1,714,249)
Non-controlling interest (396,437) (360,877)
Total stockholders' deficit (2,661,157) (2,075,126)
Total liabilities and stockholders' deficit 7,791 9,092
Series A Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock value 253 253
Series B Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock value 120 110
Series D Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock value $ 0 $ 0